HIV, health and development
Eastern Europe and Central Asia is the only region in the world where new HIV infections are rising dramatically, with almost no decline of AIDS-related deaths. Between 2010 and 2017, the rate of individuals contracting HIV in the region has increased by 30% , representing an estimated 140,000 people.
Of the 1.4 million people living with HIV in the region, only 36 % are on treatment. New infections are primarily occurring among populations at higher risk of HIV, such as people who inject drugs (approximately 39 percent), clients of sex workers, and sexual partners of these populations (28 percent). The region risks not reaching UNAIDS’ 90-90-90 targets, that by 2020 90% of people living with HIV know their HIV status, 90% with diagnosed HIV infection receive sustained antiretroviral therapy and 90% receiving antiretroviral therapy have viral suppression.
Punitive laws and policies regarding same-sex relationships, drug use and sex work continue to increase stigma towards vulnerable populations, further fueling the epidemic. Fear of prosecution keeps populations away from testing and knowing their HIV status.
Nine of the world’s 30 countries with a high burden of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) are in the Eastern Europe and Central Asia region. Less than 50% of all cases have been detected and successfully treated.
Meanwhile, non-communicable diseases (NCDs), including diabetes, cardiovascular diseases, cancer, chronic respiratory diseases and mental disorders account for an estimated 86% of the deaths and 77% of the disease burden in the region.
An already challenging health landscape is further complicated by dramatic changes in current and future funding for effective and equitable HIV and health responses.
UNDP's work in the health area focuses on:
- promoting laws, regulations and policies that help address HIV-related issues and protect the rights of key populations at higher risk of HIV, such as people who use drugs, sex workers, men who have sex with men, transgender people, migrant workers and people living with HIV;
- supporting sustainable financing of HIV and health responses by promoting access to affordable and quality HIV and other medicines of public health importance;
- identifying and promoting the most impactful and efficient investments in the HIV and TB response, and encouraging more sustainable domestic financing;
- promoting the establishment of sustainable and transparent procurement in the health sector in partnership with other UN agencies, global health financing institutions, civil society and the private sector; and
- addressing the social, economic and environmental determinants of health and health equity as critical facts for ill health.